These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15612086)

  • 1. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Masters S
    Med J Aust; 2004 Oct; 181(8):459; discussion 459. PubMed ID: 15612086
    [No Abstract]   [Full Text] [Related]  

  • 2. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Graudins LV
    Med J Aust; 2004 Oct; 181(8):458-9. PubMed ID: 15612085
    [No Abstract]   [Full Text] [Related]  

  • 3. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Woodruff TG
    Med J Aust; 2004 Oct; 181(8):458. PubMed ID: 15487968
    [No Abstract]   [Full Text] [Related]  

  • 4. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Breen KJ
    Med J Aust; 2004 Apr; 180(8):409-10. PubMed ID: 15089732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Focusing on costs is not enough].
    Verland K
    Ugeskr Laeger; 2003 Nov; 165(46):4440-1; author reply 4441. PubMed ID: 14655575
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is the pharmaceutical industry really as bad as its reputation?].
    Prat EH
    Wien Med Wochenschr; 2005 Nov; 155(21-22):502-12. PubMed ID: 16425111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicine and the pharmaceutical industry: a call to action.
    Stiles MM; Barrett B
    Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137
    [No Abstract]   [Full Text] [Related]  

  • 8. Giving and receiving of gifts between pharmaceutical and medical specialists in Australia.
    Wilson A
    Intern Med J; 2006 Dec; 36(12):795-6; author reply 796-7. PubMed ID: 17096745
    [No Abstract]   [Full Text] [Related]  

  • 9. [Economic aspects of pharmacovigilance in the pharmaceutical industry].
    Abadie E; Souetre E
    Therapie; 1993; 48(2):125-7. PubMed ID: 8351680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to manage conflicts of interest with industry?
    Schowalter JE
    Int Rev Psychiatry; 2008 Apr; 20(2):127-33. PubMed ID: 18386202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
    Kerridge I; Maguire J; Newby D; McNeill PM; Henry D; Hill S; Day R; Macdonald G; Stokes B; Henderson K
    Intern Med J; 2005 Apr; 35(4):206-10. PubMed ID: 15836497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
    Civaner M
    Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical uncertainty and moral contest: a qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia.
    Doran E; Kerridge I; McNeill P; Henry D
    Soc Sci Med; 2006 Mar; 62(6):1510-9. PubMed ID: 16143441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of the pharmaceutical industry on treatment guidelines].
    Kramers C; Wuis E; Schouwenberg B
    Ned Tijdschr Geneeskd; 2008 Jan; 152(2):114; author reply 114. PubMed ID: 18265803
    [No Abstract]   [Full Text] [Related]  

  • 15. [New thinking necessary?].
    Lindberg M
    Ugeskr Laeger; 2003 Oct; 165(41):3939-40. PubMed ID: 14579559
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethical issues in the relationships with industry: an ongoing challenge. New Guidelines open for public comment.
    Komesaroff PA
    J Paediatr Child Health; 2005 Nov; 41(11):558-60. PubMed ID: 16398836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician interaction with pharmaceutical companies: the rules are getting tougher.
    Loomis CH
    J Okla State Med Assoc; 2003 Jun; 96(6):278-9. PubMed ID: 12858819
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment: interactions between the medical profession and the pharmaceutical industry in Australia.
    Kerridge I
    Australas Psychiatry; 2008 Jun; 16(3):166-8. PubMed ID: 18568620
    [No Abstract]   [Full Text] [Related]  

  • 19. Nurses and the pharmaceutical industry: part 2.
    Olsen DP
    Am J Nurs; 2009 Feb; 109(2):86-7. PubMed ID: 19300016
    [No Abstract]   [Full Text] [Related]  

  • 20. Are drug too expensive in Canada? No.
    Williams R; Marion J
    Can Fam Physician; 2006 May; 52():573-6, 578-81. PubMed ID: 16739822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.